GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the ACVR1 kinase domain in complex with the IMIDAZO[1,2-B]PYRIDAZINE inhibitor K00135

Analyse Crystal structure of the ACVR1 kinase domain in complex with the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4DYM
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Activin receptor type-1
EC
2.7.11.30
UniProt
Q04771
Ligands
IYZ, SO4
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AActivin receptor type-1 (EC 2.7.11.30)protein29338% helix, 22% strandQ04771

Ligands and binding sites

  • IYZ · 1-(3-{6-[(cyclopropylmethyl)amino]imidazo[1,2-b]pyridazin-3-yl}phenyl)ethanone · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • GOL · Glycerol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15110.690.7945SO4, IYZ, GOL
21390.580.8327empty

Compared structures

  • 4DYM · Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q04771 · AlphaFold monomer V2.0 prediction for activin receptor type-1 (Q04771) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.